Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_provenance.
- NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_assertion description "[Reliable studies on animal models indicate that the proteolytic break-down products of apolipoprotein[a] would posses anti-angiogenic and anti-tumoral properties both in vitro and in vivo, a premise to develop novel therapeutic modalities which may efficiently suppress tumor growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_provenance.
- NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_assertion evidence source_evidence_literature NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_provenance.
- NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_assertion SIO_000772 17442497 NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_provenance.
- NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_assertion wasDerivedFrom befree-2016 NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_provenance.
- NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_assertion wasGeneratedBy ECO_0000203 NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_provenance.
- befree-2016 importedOn "2016-02-19" NP605292.RApmh7XoYfnc1S3foGDLxWuJKthUpAtr919pN5Rk_gBLs130_provenance.